Showing 1 - 16 results of 16 for search 'Chia‐Chi Lin', query time: 0.04s
Refine Results
-
1
Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors by Chia-Chi Lin
Published 2021-05-01
Article -
2
Should We Design Clinical Trials Differently in the Era of Cancer Immunotherapy? by Chia-Chi Lin
Published 2019-05-01
Article -
3
A Content Analysis of Online Physician Information by Chia-Chi Lin, Ming-Hsin Phoebe Chiu
Published 2019-07-01
Article -
4
以資源本位學習模式構建開放式課堂外教育環境:大學圖書館書法推廣活動之策展策略 by 譚丹丹 Tan Dandan, 林佳琪 Chia-Chi Lin
Published 2014-10-01
Article -
5
Antibacterial Peptide CecropinB2 Production via Various Host and Construct Systems by Wei-Shiang Lai, Shu-Chen Kan, Chia-Chi Lin, Chwen-Jen Shieh, Yung-Chuan Liu
Published 2016-01-01
Article -
6
-
7
-
8
-
9
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens by Wei‐Li Ma, Chia‐Chi Lin, Feng‐Ming Hsu, Jang‐Ming Lee, Jin‐Shing Chen, Yen‐Lin Huang, Yih‐Leong Chang, Chin‐Hao Chang, James Chih‐Hsin Yang
Published 2022-09-01
Article -
10
Determinants of coronavirus disease 2019 infection by artificial intelligence technology: A study of 28 countries. by Hsiao-Ya Peng, Yen-Kuang Lin, Phung-Anh Nguyen, Jason C Hsu, Chun-Liang Chou, Chih-Cheng Chang, Chia-Chi Lin, Carlos Lam, Chang-I Chen, Kai-Hsun Wang, Christine Y Lu
Published 2022-01-01
Article -
11
629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoin... by Jameel Muzaffar, Tae Min Kim, Julie Brahmer, Dirk G Brockstedt, Chia-Chi Lin, Michael Chisamore, Ki Hyeong Lee, Paul D Kassner, Nuttapong Ngamphaiboon, William Ho, Nicole Nasrah, Pratibha Desai, Yin-Hsun Feng, Shang-Yin Wu, Rakesh Kumar Goyal
Published 2023-11-01Article -
12
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors by Thomas Yau, Ignacio Garrido-Laguna, Pierre-Eric Juif, Markus Joerger, Anna Spreafico, Todd M Bauer, Chia-Chi Lin, Armando Santoro, Richard Greil, Helen Evans, Marc Pelletier, Toshikiko Doi, Maria-Elisabeth Goebeler, Viviana Cremasco, Marie Luise Hütter-Krönke, Antonella Perotti, Darlene Lu, Louise Barys, Claire Fabre
Published 2023-11-01
Article -
13
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine
Published 2022-01-01
Article -
14
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies by Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud
Published 2024-12-01
Article -
15
Clinical practice consensus for the diagnosis and management of melanoma in Taiwan by Chiao-En Wu, Yi-Hua Liao, Cheng-Lin Wu, Ruoh-Fang Yen, Chia-Chi Lin, Muh-Hwa Yang, Chueh-Chuan Yen, Wu-Chou Su, Chia-Jui Yen, Yi-Fang Chang, Ming-Fang Wu, Youngsen Yang, Chen-Yuan Lin, Wen-Chi Yang, Hui-Ching Wang, Cheng-Yuan Li, Yin-Yu Ho, Yao-Yu Chang, Chieh-Shan Wu, Hsiu-Cheng Hsu, Kuang-Hua Chen, Yenlin Huang, Chih-Jung Chen, Pei-Ju Chuang, Yung-Chi Lai, Yu-Yi Huang, Neng-Chuan Tseng, Yi-Ting Huang, Chia-Yu Chu, John Wen-Cheng Chang
Published 2024-01-01
Article -
16
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC by Qing Zhou, MD, PhD, Ross A. Soo, MBBS, PhD, Gee-Chen Chang, MD, PhD, Chao-Hua Chiu, MD, Hidetoshi Hayashi, MD, PhD, Sang-We Kim, MD, PhD, Shunsuke Teraoka, MD, Yasushi Goto, MD, PhD, Jianying Zhou, MD, Victor Ho-Fun Lee, MD, Dong-Wan Kim, MD, PhD, Baohui Han, MD, PhD, James Chung Man Ho, MD, FRCP, Chia-Chi Lin, MD, PhD, Shun Lu, MD, Anna Polli, BS, Anna Maria Calella, PhD, Jean-François Martini, PhD, Chew Hooi Wong, PhD, Tony Mok, MD, Hye Ryun Kim, MD, PhD, Yi-Long Wu, MD
Published 2023-05-01
Article